Menu Close

Articles on mRNA vaccine

Displaying 1 - 20 of 45 articles

Global Justice campaigners in London stand by fake coffins to highlight global COVID-19 deaths. If pharma companies waived intellectual property rights, it would be easier for low- and middle-income countries to access COVID-19 vaccines. (AP Photo/Alastair Grant)

We still need a vaccine patent waiver, but not the one on offer at the World Trade Organization meeting

Waiving patent rights on COVID-19 vaccines and drugs is still crucial to ensure access globally, but the waiver on the table at the June World Trade Organization meeting doesn’t do the job.
Nanoparticles can help cancer drugs home in on tumors and avoid damaging healthy cells. Kateryna Kon/Science Photo Library via Getty Images

Nanoparticles are the future of medicine – researchers are experimenting with new ways to design tiny particle treatments for cancer

The COVID-19 mRNA vaccines put nanomedicine in the spotlight as a potential way to treat diseases like cancer and HIV. While the field isn’t there yet, better design could help fulfill its promise.
Dozens of coronavirus vaccines are in clinical trials in the U.S. Joao Paulo Burini/Moment via Getty Images

Will new vaccines be better at fighting coronavirus variants? 5 questions answered

Existing coronavirus vaccines are not as effective against newer variants of the virus. Two vaccine experts explain how new vaccines currently in development will likely offer better protection.
Researchers are working to develop vaccines that provide long-term immune protection from COVID-19. Marko Geber/Digital Vision via Getty Images

How long does protective immunity against COVID-19 last after infection or vaccination? Two immunologists explain

Because COVID-19 is a relatively new virus, researchers still aren’t sure exactly how long vaccines and prior infections provide protection.
We interact with nanoparticles in multiple ways every day. The nanoparticles in this illustration are delivering drugs to cells. (Shutterstock)

The nanoparticles in mRNA vaccines are nothing to fear: We interact with many useful, tiny particles every day

Some vaccine hesitancy is based on a fear of the nanoparticles used in mRNA vaccines. But humans have been interacting with nanoparticles for millennia, and we use nanotechnology-based devices every day.
Pharmacist Barbara Violo arranges all the empty vials of the AstraZeneca COVID-19 vaccine that she has provided to customers at an independent pharmacy in Toronto. THE CANADIAN PRESS/Nathan Denette

AstraZeneca second dose: Should I get the same vaccine or choose Pfizer or Moderna?

Hundreds of thousands of Canadians got a shot of AstraZeneca’s COVID-19 vaccine for their first dose. They now have a choice for their second dose: AstraZeneca again, or Pfizer or Moderna mRNA vaccine?
People line up at a mass vaccination centre during the COVID-19 pandemic in Mississauga, Ont. THE CANADIAN PRESS/Nathan Denette

Public health officials are failing to communicate effectively about AstraZeneca

Canadian public health organizations have run into a serious communication problem about the AstraZeneca vaccine. Crisis management and communication theories explain what’s gone wrong.

Top contributors

More